þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Florida | 65-0977964 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
35 Sawgrass Drive, Suite 2 Bellport, NY | 11713 | |
(Address of principal executive offices) | (Zip Code) |
Large Accelerated Filer | o | Accelerated Filer | ¨ | |||
Non-accelerated Filer | o (Do not check if a smaller reporting company) | Smaller Reporting Company | þ | |||
Emerging Growth Company | o | |||||
If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o |
ITEM 1 | ||
ITEM 2 | ||
ITEM 3 | ||
ITEM 4 | ||
PART II OTHER INFORMATION | ||
ITEM 1 | ||
ITEM 1A | ||
ITEM 2 | ||
ITEM 3 | ||
ITEM 4 | ||
ITEM 5 | ||
ITEM 6 | ||
PART I. | FINANCIAL INFORMATION |
ITEM 1. | FINANCIAL STATEMENTS |
April 29, 2017 | January 28, 2017 | ||||||
(unaudited) | (Note 1) | ||||||
ASSETS: | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 1,848 | $ | 7,474 | |||
Accounts receivable, net of allowances of $2,427 and $2,267 as of April 29, 2017 and January 28, 2017, respectively | 31,614 | 28,072 | |||||
Inventories | 193,083 | 196,654 | |||||
Prepaid expenses and other current assets | 9,829 | 10,619 | |||||
Total current assets | 236,374 | 242,819 | |||||
Property and equipment, net | 15,818 | 16,692 | |||||
Goodwill | 38,769 | 38,769 | |||||
Intangible and other assets, net | 13,778 | 14,520 | |||||
Total assets | $ | 304,739 | $ | 312,800 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY: | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 27,506 | $ | 28,605 | |||
Accounts payable-affiliates | 546 | 1,027 | |||||
Accrued expenses and other liabilities | 28,507 | 31,186 | |||||
Current portion of obligations under capital leases | 898 | 1,237 | |||||
Total current liabilities | 57,457 | 62,055 | |||||
Revolving credit facility | 4,517 | — | |||||
Notes payable-affiliates | 125,366 | 125,366 | |||||
Other long-term liabilities | 66,593 | 64,954 | |||||
Total liabilities | 253,933 | 252,375 | |||||
Commitments and contingencies | |||||||
Shareholders’ equity: | |||||||
Preferred stock, $0.10 par value, 1,000,000 shares authorized; as of April 29, 2017 and January 28, 2017, none issued | — | — | |||||
Common stock, $.01 par value, 35,000,000 shares authorized; 16,392,012 shares issued as of April 29, 2017 and January 28, 2017 | 164 | 164 | |||||
Additional paid-in capital | 222,082 | 222,048 | |||||
Accumulated deficit | (162,863 | ) | (153,210 | ) | |||
Treasury stock, at cost, 898,249 shares as of April 29, 2017 and January 28, 2017 | (8,577 | ) | (8,577 | ) | |||
Total shareholders’ equity | 50,806 | 60,425 | |||||
Total liabilities and shareholders’ equity | $ | 304,739 | $ | 312,800 | |||
Thirteen Weeks Ended April 29, 2017 | Thirteen Weeks Ended April 30, 2016 | |||||||
Net sales | $ | 97,896 | $ | 105,139 | ||||
Cost of goods sold | 52,927 | 53,370 | ||||||
Gross profit | 44,969 | 51,769 | ||||||
Operating expenses: | ||||||||
Selling, general and administrative expenses | 50,932 | 53,928 | ||||||
Share-based compensation expense | 34 | 32 | ||||||
Depreciation and amortization | 1,531 | 2,511 | ||||||
Total operating expenses | 52,497 | 56,471 | ||||||
Loss from operations | (7,528 | ) | (4,702 | ) | ||||
Interest expense | 2,125 | 1,707 | ||||||
Loss before income tax provision | (9,653 | ) | (6,409 | ) | ||||
Income tax provision | — | — | ||||||
Net loss | $ | (9,653 | ) | $ | (6,409 | ) | ||
Net loss per common share: | ||||||||
Basic and diluted | $ | (0.62 | ) | $ | (0.41 | ) | ||
Weighted average number of common shares outstanding: | ||||||||
Basic | 15,493,763 | 15,493,763 | ||||||
Diluted | 15,493,763 | 15,493,763 |
Additional | |||||||||||||||||||||||||
Common Stock | Paid-In | Accumulated | Treasury Stock | ||||||||||||||||||||||
Shares | Amount | Capital | Deficit | Shares | Amount | Total | |||||||||||||||||||
Balance at January 28, 2017 | 16,392,012 | $ | 164 | $ | 222,048 | $ | (153,210 | ) | 898,249 | $ | (8,577 | ) | $ | 60,425 | |||||||||||
Share-based compensation expense | — | — | 34 | — | — | — | 34 | ||||||||||||||||||
Net loss | — | — | — | (9,653 | ) | — | — | (9,653 | ) | ||||||||||||||||
Balance at April 29, 2017 | 16,392,012 | $ | 164 | $ | 222,082 | $ | (162,863 | ) | 898,249 | $ | (8,577 | ) | $ | 50,806 |
Thirteen Weeks Ended April 29, 2017 | Thirteen Weeks Ended April 30, 2016 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (9,653 | ) | $ | (6,409 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Amortization of deferred financing costs | 86 | 86 | |||||
Depreciation and amortization | 1,531 | 2,511 | |||||
Provision for losses on accounts receivable | 164 | 1,787 | |||||
Share-based compensation | 34 | 32 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | (3,706 | ) | (7,181 | ) | |||
Inventories | 3,571 | 7,487 | |||||
Prepaid expenses and other assets | 1,084 | 405 | |||||
Accounts payable | (1,099 | ) | 1,919 | ||||
Accounts payable-affiliates | (481 | ) | (120 | ) | |||
Accrued expenses and other liabilities and other long-term liabilities | (1,040 | ) | (1,187 | ) | |||
Net cash used in operating activities | (9,509 | ) | (670 | ) | |||
Cash flows from investing activities: | |||||||
Additions to property and equipment | (295 | ) | (809 | ) | |||
Net cash used in investing activities | (295 | ) | (809 | ) | |||
Cash flows from financing activities: | |||||||
Net borrowings (repayments) under bank line of credit | 4,517 | (989 | ) | ||||
Principal payments under capital lease obligations | (339 | ) | (285 | ) | |||
Net cash provided by (used in) financing activities | 4,178 | (1,274 | ) | ||||
Net decrease in cash and cash equivalents | (5,626 | ) | (2,753 | ) | |||
Cash and cash equivalents at beginning of period | 7,474 | 5,640 | |||||
Cash and cash equivalents at end of period | $ | 1,848 | $ | 2,887 | |||
Supplemental Information: | |||||||
Cash paid during the period for: | |||||||
Interest | $ | 71 | $ | 214 | |||
Income taxes | $ | 17 | $ | 109 |
April 29, 2017 | January 28, 2017 | ||||||||||||||||||||||||
Useful Life (years) | Original Cost | Accumulated Amortization | Net Book Value | Original Cost | Accumulated Amortization | Net Book Value | |||||||||||||||||||
Goodwill | N/A | $ | 38,769 | $ | — | $ | 38,769 | $ | 38,769 | $ | — | $ | 38,769 | ||||||||||||
Tradenames | 4-20 | 9,357 | 8,181 | 1,176 | 9,357 | 8,084 | 1,273 | ||||||||||||||||||
Customer relationships | 10 | 5,171 | 2,629 | 2,542 | 5,171 | 2,500 | 2,671 | ||||||||||||||||||
Favorable leases | 7 | 886 | 886 | — | 886 | 886 | — | ||||||||||||||||||
License agreements | 3-5 | 16,313 | 15,779 | 534 | 16,313 | 15,643 | 670 | ||||||||||||||||||
Tradename (non-amortizing) | N/A | 7,180 | — | 7,180 | 7,180 | — | 7,180 | ||||||||||||||||||
$ | 77,676 | $ | 27,475 | $ | 50,201 | $ | 77,676 | $ | 27,113 | $ | 50,563 |
Fiscal Year | Amortization Expense | |||
Remainder of 2017 | $ | 1,065 | ||
2018 | 877 | |||
2019 | 709 | |||
2020 | 684 | |||
2021 | 682 | |||
2022 | 235 | |||
$ | 4,252 |
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value (in thousands) | |||||||||
Outstanding as of January 28, 2017 | 1,184,000 | $ | 6.07 | |||||||||
Granted | — | — | ||||||||||
Exercised | — | — | ||||||||||
Forfeited | (100,000 | ) | 7.70 | |||||||||
Outstanding as of April 29, 2017 | 1,084,000 | $ | 5.92 | 6.9 | $ | — | ||||||
Vested and expected to vest as of April 29, 2017 | 709,834 | $ | 7.79 | 6.9 | $ | — | ||||||
Exercisable as of April 29, 2017 | 709,834 | $ | 7.79 | 6.9 | $ | — |
Number of Warrants | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life | Aggregate Intrinsic Value (in thousands) | |||||||||
Outstanding as of January 28, 2017 | 6,299,971 | $ | 11.80 | |||||||||
Granted | — | — | ||||||||||
Exercised | — | — | ||||||||||
Forfeited | (2,133,332 | ) | 8.00 | |||||||||
Outstanding as of April 29, 2017 | 4,166,639 | $ | 13.74 | 1.8 | $ | — | ||||||
Vested and expected to vest as of April 29, 2017 | 4,166,639 | $ | 13.74 | 1.8 | $ | — | ||||||
Exercisable as of April 29, 2017 | 4,166,639 | $ | 13.74 | 1.8 | $ | — |
April 29, 2017 | January 28, 2017 | ||||||
(in thousands) | |||||||
Revolving credit facility, interest payable monthly, secured by a pledge of substantially all of the Company's assets | $ | 4,517 | $ | — | |||
Subordinated notes payable-affiliates | 125,366 | 125,366 | |||||
129,883 | 125,366 | ||||||
Less current portion | — | — | |||||
Total long-term debt | $ | 129,883 | $ | 125,366 |
Total Purchases Thirteen Weeks Ended April 29, 2017 | Total Purchases Thirteen Weeks Ended April 30, 2016 | Balance Due April 29, 2017 | Balance Due January 28, 2017 | ||||||||||||
Lighthouse Companies | $ | — | $ | — | $ | 90 | $ | 90 | |||||||
Jacavi | 311 | 1,449 | — | 590 | |||||||||||
Quality King | — | 13 | — | — | |||||||||||
Reba | — | 122 | 357 | 337 | |||||||||||
$ | 311 | $ | 1,584 | $ | 447 | $ | 1,017 |
Thirteen Weeks Ended April 29, 2017 | Thirteen Weeks Ended April 30, 2016 | ||||||
(in thousands) | |||||||
Net sales: | |||||||
Wholesale | $ | 51,102 | $ | 53,464 | |||
Retail | 46,794 | 51,675 | |||||
$ | 97,896 | $ | 105,139 | ||||
Gross profit: | |||||||
Wholesale | $ | 22,833 | $ | 25,440 | |||
Retail | 22,136 | 26,329 | |||||
$ | 44,969 | $ | 51,769 | ||||
April 29, 2017 | January 28, 2017 | ||||||
Total assets: | |||||||
Wholesale | $ | 699,812 | $ | 681,055 | |||
Retail | 368,466 | 364,117 | |||||
1,068,278 | 1,045,172 | ||||||
Eliminations (a) | (763,539 | ) | (732,372 | ) | |||
Consolidated assets | $ | 304,739 | $ | 312,800 |
(a) | Adjustment to eliminate intercompany receivables and investment in subsidiaries |
Thirteen Weeks Ended April 29, 2017 | Percentage of Net Sales | Thirteen Weeks Ended April 30, 2016 | Percentage of Net Sales | Dollar Change | |||||||||||
($ in thousands) | |||||||||||||||
Wholesale | $ | 51,102 | 52.2% | $ | 53,464 | 50.9% | $ | (2,362 | ) | ||||||
Retail | 46,794 | 47.8% | 51,675 | 49.1% | (4,881 | ) | |||||||||
Total net sales | $ | 97,896 | 100% | $ | 105,139 | 100% | $ | (7,243 | ) |
Thirteen Weeks Ended April 29, 2017 | Thirteen Weeks Ended April 30, 2016 | Dollar Change | ||||||||||
($ in thousands) | ||||||||||||
Wholesale | $ | 22,833 | $ | 25,440 | $ | (2,607 | ) | |||||
Retail | 22,136 | 26,329 | (4,193 | ) | ||||||||
Total gross profit | $ | 44,969 | $ | 51,769 | $ | (6,800 | ) |
Thirteen Weeks Ended April 29, 2017 | Thirteen Weeks Ended April 30, 2016 | |||
Wholesale | 44.7% | 47.6% | ||
Retail | 47.3% | 51.0% | ||
Total gross profit percentage | 45.9% | 49.2% |
ITEM 4. | CONTROLS AND PROCEDURES |
PART II. | OTHER INFORMATION |
ITEM 1. | LEGAL PROCEEDINGS |
ITEM 1A. | RISK FACTORS |
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
ITEM 4. | MINE SAFETY DISCLOSURES |
ITEM 5. | OTHER INFORMATION |
ITEM 6. | EXHIBITS |
3.1 | Amended and Restated Articles of Incorporation, as amended through August 8, 2008 (Incorporated by reference to Exhibit 3.1 to the Company's Form 10-K filed July 2, 2009). | ||
3.2 | Articles of Amendment to Amended and Restated Articles of Incorporation, filed April 17, 2012 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed April 19, 2012). | ||
3.3 | Bylaws (Incorporated by reference to Exhibit 3.2 to the Company's Registration Statement on Form S-1 (No 33-46833)). | ||
10.1 | Form of Indemnification Agreement dated March 27, 2017 between the Company and each of its directors and executive officers. | ||
31.1 | Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2 | Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32.1 | Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
32.2 | Certification by Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | XBRL Instance Document | ||
101.SCH | XBRL Taxonomy Extension Schema Document | ||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | ||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | ||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | ||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
PERFUMANIA HOLDINGS, INC. (Registrant) | ||||
Date: | June 19, 2017 | By: | By: /s/ Michael W. Katz | |
Michael W. Katz | ||||
President and Chief Executive Officer | ||||
(Principal Executive Officer) | ||||
By: | By: /s/ Michael P. Nofi | |||
Michael P. Nofi | ||||
Chief Financial Officer | ||||
(Principal Financial and Accounting Officer) |
1. | Definitions. The following definitions will apply for purposes of this Agreement: |
(a) | a change in control of the Company occurring after the Effective Date of a nature that would be required to be reported in response to Item 5.01 of Current Report on Form 8-K (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange Act of 1934 (the “Act”), whether or not the Company is then subject to such reporting requirement; provided, however, that, without limiting the foregoing, a change in control shall be deemed to have occurred if, after the Effective Date, any “person” (as such term is used in Sections 13(d) and 14(d) of the Act) becomes the “beneficial owner” (as defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities without the prior approval of at least two-thirds of the members of the Board in office immediately prior to such person’s attaining of such percentage; |
(b) | a merger, consolidation, sale of assets or other transaction to which the Company is a party, or a proxy contest, as a consequence of which members of the Board in office immediately prior to such transaction or proxy contest constitute less than a majority of the Board thereafter; or |
(c) | during any period of two consecutive years, individuals who at the beginning of such period constituted the Board (including, without limitation, for this purpose any new director whose election or nomination for election by the Company’s shareholders was approved by a vote of at least a majority of the directors then still in office who were directors at the beginning of such period) cease for any reason to constitute at least a majority of the Board. |
2. | Liability Insurance. |
(a) | Maintenance of Insurance. The Company agrees that as long as the Indemnitee shall continue to serve as an Agent and thereafter so long as the Indemnitee shall be subject to any Proceeding or possible Proceeding by reason of the fact that the Indemnitee is or was an Agent, the Company shall obtain and maintain in full force and effect directors and officers liability insurance from established and reputable insurers for the benefit of the Company and its Agents with aggregate limits not less than the limits of, and having other terms not less favorable to the insured persons than, the directors and officers liability insurance maintained by the Company as of the Effective Date (the “D&O Insurance”). The D&O Insurance shall not contain any provision that limits or impacts adversely any right or privilege granted to the Indemnitee under this Agreement. |
(b) | “Tail” Insurance. |
(i) | Upon a Triggering Event; or |
(ii) | in the event that the D&O Insurance is to be cancelled or terminated or will not be renewed (such cancellation, termination or non-renewal being called a “Lapse Event”); |
3. | Mandatory Indemnification. Except as otherwise provided in this Agreement, the Company shall indemnify the Indemnitee to the fullest extent permitted by the Florida Business Corporation Act as such law may from time to time be amended, as follows: |
(a) | Non-Derivative Actions. If the Indemnitee is or was a party to or is or was threatened to be made a party to any Proceeding (other than an action by or in the right of the Company) by reason of the fact that the Indemnitee is or was an Agent, or by reason of anything done or not done by the Indemnitee in any such capacity, the Indemnitee shall be indemnified against any and all Liabilities and Expenses actually and reasonably incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of such Proceeding if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or Proceeding, the Indemnitee had no reasonable cause to believe that the Indemnitee’s conduct was unlawful; and |
(b) | Derivative Actions. If the Indemnitee is or was a party to or is threatened to be made a party to any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of the fact that the Indemnitee is or was an Agent, or by reason of anything done or not done by the Indemnitee in any such capacity, the Indemnitee |
4. | Partial Indemnification. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of any Liabilities or Expenses incurred by the Indemnitee in the investigation, defense, settlement or appeal of a Proceeding but the Indemnitee is not entitled, however, to indemnification for the total amount thereof, the Company shall nevertheless indemnify the Indemnitee for such total amount minus the portion thereof to which the Indemnitee is not entitled. |
5. | Advancement of Expenses; and Payment of Certain Fees. |
(a) | Mandatory Advancement. Subject to Section 9 below, the Company shall advance all Expenses incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of any Proceeding to which the Indemnitee is a party or is threatened to be made a party by reason of the fact that the Indemnitee is or was an Agent or by reason of anything done or not done by the Indemnitee in any such capacity. The Indemnitee hereby undertakes to repay such amounts advanced only if, and to the extent that, it shall ultimately be determined that the Indemnitee is not entitled to be indemnified by the Company as authorized under this Agreement. The advances to be made under this Section 5(a), shall be paid by the Company to the Indemnitee within twenty (20) days following the giving of notice by the Indemnitee to the Company for such advance together with an undertaking as described in this Section 5(a). |
(b) | Hourly Payments. In the event of any Proceeding against the Indemnitee with respect to which any indemnification of the Indemnitee under this Agreement applies or reasonably could apply, the Company shall pay the Indemnitee at the rate of Three Hundred Dollars ($300.00) for each hour reasonably spent by the Indemnitee for participating (at the request of the Company, or pursuant to any subpoena, court or |
6. | Notice and Other Indemnification Procedures. |
(a) | Within thirty (30) days after the Indemnitee receives notice of a Proceeding, as to which indemnification, or advancement of Expenses, may pertain, the Indemnitee shall, if the Indemnitee believes that indemnification with respect thereto may be sought from the Company under this Agreement, give notice to the Company of such Proceeding; provided, however, that failure of the Indemnitee to give such notice during such thirty (30) day period shall not alter, limit or eliminate the Indemnitee’s right to indemnification under this Agreement with respect to such Proceeding. |
(b) | The Company shall give prompt notice, that the Company has received, of such Proceeding to the insurers of the D&O Insurance or the “tail” insurance described in Section 2(b) in accordance with the procedures set forth in the applicable insurance policy or policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policy or policies. |
(c) | In the event the Company shall be obligated under this Agreement to advance Expenses to the Indemnitee with respect to any Proceeding, the Company shall be entitled to assume the defense of such Proceeding, with counsel approved by the Indemnitee, upon notice being given to the Indemnitee of its election so to do. After such notice has been given, approval of such counsel by the Indemnitee and the retention of such counsel by the Company, except as provided in Section 6(d), the Company will not be liable to the Indemnitee under this Agreement for any fees or expenses of counsel subsequently incurred by the Indemnitee with respect to such Proceeding. The Indemnitee shall have the right to employ the Indemnitee’s separate counsel in any such Proceeding at the Indemnitee’s expense. |
(d) | In the event that: |
(i) | the Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee with respect to the defense of such Proceeding; |
(ii) | the Company shall not have engaged counsel to assume the defense of such Proceeding within a reasonable time after the Company has notice of such Proceeding; or |
(iii) | the Company, having assumed the defense of such Proceeding, does not vigorously defend such Proceeding; |
(a) | To the extent the Indemnitee has been successful on the merits or otherwise in defense of any Proceeding referred to in Section 3(a) or Section 3(b) of this Agreement or in the defense of any claim, issue or matter described therein, the Company shall indemnify the Indemnitee against Liabilities and Expenses actually and reasonably incurred by the Indemnitee in connection therewith. |
(b) | In the event that Section 7(a) is inapplicable, the Company shall nevertheless indemnify the Indemnitee unless, and only to the extent that, the Company shall prove by clear and convincing evidence to a forum described in Section 7(c) below that the Indemnitee has not met the applicable standard of conduct required to entitle the Indemnitee to such indemnification. |
(c) | The Indemnitee shall be entitled to select, from among the following, the forum in which the validity of the Company’s claim under Section 7(b) that the Indemnitee is not entitled to indemnification will be heard: |
(d) | As soon as practicable, and in no event later than 30 days after notice of the Indemnitee’s choice of forum pursuant to Section 7(c) above has been given, the Company shall, at its own expense, submit to the selected forum in such manner as the Indemnitee or the Indemnitee’s counsel may reasonably request, the Company’s claim (if any) that the Indemnitee is not entitled to indemnification, and the Company shall act in the utmost good faith to assure the Indemnitee a complete opportunity to defend against such claim. |
(e) | Notwithstanding a determination by any forum listed in Section 7(c) hereof that the Indemnitee is not entitled to indemnification with respect to a specific Proceeding, the Indemnitee shall have the right to apply to the court in which that Proceeding is or was pending or any other court of competent jurisdiction, for the purpose of enforcing the Indemnitee’s right to indemnification pursuant to this Agreement. |
(f) | The Company agrees that if there is a Triggering Event (other than a Triggering Event that has been approved by a majority of members the Board which majority were directors immediately prior to such Triggering Event) then with respect to all matters thereafter arising concerning the rights of the Indemnitee to indemnification under the Company’s articles of incorporation or bylaws, this Agreement or any other agreement, or any other document now or hereafter in effect relating to such indemnification, the Company shall seek legal advice only from Independent Counsel selected by the Indemnitee. The Company agrees to pay the reasonable fees of such Independent Counsel and to indemnify fully such counsel against any and all attorneys’ fees and expenses, claims, liabilities and damages arising out of or relating to this Agreement or such Independent Counsel’s engagement pursuant hereto. |
(g) | The Company shall indemnify the Indemnitee against all Expenses incurred by the Indemnitee in connection with any Proceeding under this Section 7 involving the Indemnitee and against all Expenses incurred by the Indemnitee in connection with any other Proceeding between the Company and the Indemnitee involving the interpretation or enforcement of the rights of the Indemnitee under this Agreement unless a court of competent jurisdiction has determined, by a final, non-appealable judgment, that the material claims or defenses of the Indemnitee in any such Proceeding were frivolous or not made in good faith. |
8. | Notice of Claims Against Indemnitee. It shall be a condition precedent to the assertion by or on behalf of the Company or any Subsidiary of a claim against the Indemnitee, the Indemnitee’s spouse, heirs, estate or personal representatives that notice of such claim shall have been given to the Indemnitee within one year after the act or omission of the Indemnitee upon which such claim is based; provided, however, if the Indemnitee has fraudulently concealed the facts underlying such claim, it shall be a condition precedent to the assertion |
9. | Exceptions. Any other provision of this Agreement to the contrary notwithstanding, the Company shall not be obligated pursuant to the terms of this Agreement to: |
(a) | Indemnify the Indemnitee or advance Expenses to the Indemnitee with respect to Proceedings initiated or brought voluntarily by the Indemnitee and not by way of defense, except with respect to Proceedings brought to establish or enforce a right to indemnification under this Agreement or any other statute or law or otherwise as required under Florida law, but such indemnification or advancement of Expenses may be provided by the Company in specific cases if the Board determines it to be appropriate; or |
(b) | indemnify the Indemnitee for any Expenses incurred by the Indemnitee with respect to any Proceeding instituted by the Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines, by a final, non-appealable judgment, that the material assertions made by the Indemnitee in such Proceeding were not made in good faith or were frivolous; or |
(c) | indemnify the Indemnitee under this Agreement for any amounts paid in settlement of a Proceeding unless the Company consents to such settlement; or |
(d) | indemnify the Indemnitee or advance Expenses to the Indemnitee under this Agreement with respect to any Proceeding brought by the Company against the Indemnitee for willful misconduct, unless a court of competent jurisdiction shall have determined by a final, non-appealable judgment, that the claims by the Company in such Proceeding were not made in good faith or were frivolous; or |
(e) | indemnify the Indemnitee for Expenses and the payment of profits arising from the purchase and sale by the Indemnitee of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute; or |
(f) | indemnify the Indemnitee on account of the Indemnitee’s conduct which is finally adjudged by a final, non-appealable judgment of a court of competent jurisdiction to have been knowingly fraudulent or deliberately dishonest, or to constitute willful misconduct; or |
(g) | indemnify the Indemnitee if a final, non-appealable judgment of a court of competent jurisdiction shall have determined that such indemnification is not lawful; or |
(h) | indemnify the Indemnitee for the payment of amounts required to be reimbursed to the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002, as amended, or any similar successor statute. |
10. | Non-Exclusivity. The provisions for indemnification and advancement of Expenses under the terms of this Agreement shall not be deemed exclusive of any other rights which the Indemnitee may have under any provision of law, the Company’s articles of incorporation or bylaws, the vote of the Company’s shareholders or disinterested directors, other agreements, or otherwise, both as to actions in the Indemnitee’s official capacity and to actions in any other capacity while occupying the Indemnitee’s position as an Agent, and the Indemnitee’s rights under this Agreement shall continue after the Indemnitee has ceased acting as an Agent and shall inure to the benefit of the heirs, estate and personal representatives of the Indemnitee. |
11. | Interpretation of Agreement. The parties intend that this Agreement will be interpreted and enforced so as to provide indemnification to the Indemnitee to the fullest extent now or hereafter permitted by law. |
12. | Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever, (a) the validity, legality and enforceability of the remaining provisions of the Agreement (including, without limitation, all portions of any Sections of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby, and (b) to the fullest extent possible, the provisions of this Agreement (including, without limitation, all portions of any Sections of this Agreement containing any such provisions held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested by the provisions held invalid, illegal or unenforceable and to give effect to Section 11 hereof. |
13. | Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision of this Agreement (whether or not similar) nor shall such waiver constitute a continuing waiver. |
14. | Successors and Assigns. The terms of this Agreement shall bind, and shall inure to the benefit of, the Company and its successors and permitted assigns, on the one hand, and the Indemnitee and the Indemnitee’s heirs, estate, personal representatives and permitted assigns, on the other hand. Neither party may assign any of its rights or delegate any of its duties under this Agreement without the prior written consent of the other party, which consent may be granted or withheld in the sole discretion of the other party. |
15. | Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given and received (a) when delivered by hand and receipted for by the party addressee, (b) when delivered by nationally recognized courier service, or (c) on the fifth day after being mailed by certified or registered mail with postage prepaid, return receipt requested, and in each of the foregoing cases, addressed to intended party at the address of such party shown on the signature page of this Agreement. Either party may change such party’s address for the giving of notices, requests, demands and other communications, or the person to whose attention such notices, requests, demands and other communications are to be given, by giving notice of such change to the other party in accordance with this Section. |
16. | Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida without taking into account conflicts of laws rules or principles that could result in the application of the laws of any other jurisdiction. |
17. | Consent to Jurisdiction. The Company and the Indemnitee each hereby irrevocably consent to the exclusive jurisdiction and venue of the courts of the State of Florida for all purposes in connection with any Proceeding which arises out of or relates to this Agreement. |
THE COMPANY: | ||
PERFUMANIA HOLDINGS, INC. | ||
By: | ||
Name: | ||
Title: | ||
Address of the Company: | ||
Name: | ||
Address of the Indemnitee: | ||
(1) | I have reviewed this report on Form 10-Q of Perfumania Holdings, Inc.; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report. |
(4) | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: June 19, 2017 |
By: /s/ Michael W. Katz |
Michael W. Katz |
President and Chief Executive Officer |
(1) | I have reviewed this report on Form 10-Q of Perfumania Holdings, Inc.; |
(2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report. |
(4) | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: June 19, 2017 | |
By: /s/ Michael P. Nofi | |
Michael P. Nofi | |
Chief Financial Officer |
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: /s/ Michael W. Katz |
Michael W. Katz |
President and Chief Executive Officer |
June 19, 2017 |
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: /s/ Michael P. Nofi |
Michael P. Nofi |
Chief Financial Officer |
June 19, 2017 |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Apr. 29, 2017 |
Jun. 16, 2017 |
|
Entity Information [Line Items] | ||
Entity Registrant Name | Perfumania Holdings, Inc. | |
Entity Central Index Key | 0000880460 | |
Current Fiscal Year End Date | --02-03 | |
Entity Filer Category | Smaller Reporting Company | |
Document Type | 10-Q | |
Document Period End Date | Apr. 29, 2017 | |
Document Fiscal Year Focus | 2016 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 15,493,763 |
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands |
Oct. 29, 2016 |
Jan. 30, 2016 |
---|---|---|
Accounts receivable, allowance for doubtful accounts | $ 3,016 | $ 1,233 |
Preferred stock par value | $ 0.10 | $ 0.10 |
Preferred stock shares authorized | 1,000,000 | 1,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Common stock par value | $ 0.01 | $ 0.01 |
Common stock shares authorized | 35,000,000 | 35,000,000 |
Common stock shares issued | 16,392,012 | 16,392,012 |
Treasury stock shares | 898,249 | 898,249 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Apr. 29, 2017 |
Apr. 30, 2016 |
|
Net sales | $ 97,896 | $ 105,139 |
Cost of goods sold | 52,927 | 53,370 |
Gross profit | 44,969 | 51,769 |
Operating expenses: | ||
Selling, General and Administrative Expenses | 50,932 | 53,928 |
Share-based compensation expense | 34 | 32 |
Depreciation and amortization | 1,531 | 2,511 |
Total operating expenses | 52,497 | 56,471 |
Income (loss) from operations | (7,528) | (4,702) |
Interest expense | 2,125 | 1,707 |
Income (loss) before income tax provision | (9,653) | (6,409) |
Income Tax Provision | 0 | 0 |
Net income (loss) | $ (9,653) | $ (6,409) |
Net income (loss) per common share: | ||
Basic and diluted | $ (0.62) | $ (0.41) |
Weighted average number of common shares outstanding: | ||
Basic | 15,493,763 | 15,493,763 |
Diluted | 15,493,763 | 15,493,763 |
Condensed Consolidated Statement of Shareholders' Equity - 3 months ended Apr. 29, 2017 - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Treasury Stock [Member] |
---|---|---|---|---|---|
Balance, shares at Jan. 28, 2017 | 16,392,012 | 898,249 | |||
Balance at Jan. 28, 2017 | $ 60,425 | $ 164 | $ 222,048 | $ (153,210) | $ (8,577) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Share-based compensation expense | 34 | 34 | |||
Net loss | (9,653) | (9,653) | |||
Balance, shares at Apr. 29, 2017 | 16,392,012 | 898,249 | |||
Balance at Apr. 29, 2017 | $ 50,806 | $ 164 | $ 222,082 | $ (162,863) | $ (8,577) |
Basis of Presentation and Operations |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
Basis of Presentation and Operations [Abstract] | |
Basis of Presentation and Operations | BASIS OF PRESENTATION AND OPERATIONS The condensed consolidated balance sheet of Perfumania Holdings, Inc. and Subsidiaries (the "Company") as of January 28, 2017, which has been derived from our audited financial statements as of and for the year ended January 28, 2017, and the accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. Certain information and note disclosures normally included in annual financial statements, prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), have been condensed or omitted pursuant to those rules and regulations. The financial information presented herein, which is not necessarily indicative of results to be expected for the full current fiscal year, reflects all adjustments which, in the opinion of management, are necessary for a fair presentation of the interim unaudited condensed consolidated financial statements. Such adjustments are of a normal, recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 28, 2017. Due to the seasonality of the Company’s business, with the most significant activity occurring from September through December each year, the results of operations for the thirteen weeks ended April 29, 2017 are not necessarily indicative of results to be expected for the full fiscal year. The Company is an independent, national, vertically integrated wholesale distributor and specialty retailer of perfumes and fragrances that conducts business through six wholly-owned operating subsidiaries; Perfumania, Inc. (“Perfumania”), Quality King Fragrance, Inc. (“QFG”), Perfumania.com, Inc. (“Perfumania.com”), Parlux Fragrances, LLC ("Parlux"), Five Star Fragrance Company, Inc. (“Five Star”) and Scents of Worth, Inc. ("SOW"). We operate in two industry segments, wholesale distribution and specialty retail sales of designer fragrances and related products. Our wholesale businesses include QFG, Parlux and Five Star. QFG distributes designer fragrances to mass market retailers, drug and other chain stores, retail wholesale clubs, traditional wholesalers, and other distributors throughout the United States. The Company sells principally to retailers such as Burlington Coat Factory, CVS, Kohl's, Marshalls, Nordstrom Rack, Ross Stores, Sears, Target, Wal-Mart and Walgreens. The Company’s manufacturing divisions, Parlux and Five Star, own and license designer and other fragrance brands that are sold to regional and national department stores, including Belk, Bon Ton, Boscovs, Dillards, Lord & Taylor, Macy's and Stage Stores, international distributors, on military bases throughout the United States, by QFG and through the Company's retail business which is discussed below. Parlux also fulfills a selection of fragrances for several online retailers, shipping directly to their customers and billing the retailers. Five Star also manufactures, on behalf of Perfumania, the Jerome Privee product line, which includes bath and body products and which is sold exclusively in Perfumania's retail stores. All manufacturing operations of Parlux and Five Star are outsourced. Our retail business is conducted through the following subsidiaries: •Perfumania, a specialty retailer of fragrances and related products, •Perfumania.com, an Internet retailer of fragrances and other specialty items, and •SOW, which sells fragrances in retail stores on a consignment basis. As of April 29, 2017, Perfumania operated a chain of 240 retail stores specializing in the sale of fragrances and related products at discounted prices up to 75% below the manufacturers’ suggested retail prices. Perfumania.com, our Company-owned website, offers a selection of our more popular products for sale online. SOW operates a national designer fragrance consignment program, with contractual relationships to sell products on a consignment basis in approximately 1,100 stores, including approximately 600 Kmart locations nationwide. Its other retail customers include Bealls, K & G and Steinmart. |
Recent Accounting Pronouncements |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract] | |
Recent Accounting Pronouncements | RECENT ACCOUNTING PRONOUNCEMENTS In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330). The amendments, which apply to inventory that is measured using any method other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost or net realizable value. ASU 2015-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016 and should be applied on a prospective basis. The Company adopted ASU No. 2015-11 prospectively effective January 29, 2017. There was no impact to the Company's consolidated financial statements. |
Allowance for Doubtful Accounts (Notes) |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
Receivables [Abstract] | |
Allowance for Credit Losses [Text Block] | ALLOWANCE FOR DOUBTFUL ACCOUNTS The Company's accounts receivable consist primarily of trade receivables due from wholesale customers. In May 2016, a Panama based customer of Parlux that distributes in certain Latin American countries was placed on the Specially Designated Nationals list by the Office of Foreign Assets Control of the U.S. Treasury Department. As a result, the customer's assets have been frozen and any dealings between U.S. companies, including Parlux, and the customer have been prohibited. Accordingly, during the thirteen weeks ended April 30, 2016, management reserved the outstanding accounts receivable balance from the customer of approximately $1.7 million due to the uncertainty of future collection of these receivables. |
Goodwill and Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets | GOODWILL AND INTANGIBLE ASSETS Goodwill in the amount of $38.8 million at April 29, 2017 and January 28, 2017 resulted from the April 18, 2012 acquisition of Parlux. The following table provides information related to goodwill and intangible assets (in thousands). Intangible assets are included in intangible and other assets, net on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017:
In accordance with US GAAP, goodwill and intangible assets with indefinite lives are not amortized, but rather tested for impairment at least annually by comparing the estimated fair values to their carrying values. Trademarks, including tradenames and owned licenses having finite lives, are amortized over their respective lives to their estimated residual values and are also reviewed for impairment in accordance with accounting standards when changes in circumstances indicate the assets’ values may be impaired. Customer relationships are amortized over the expected period of benefit and license agreements are amortized over the remaining contractual term. Impairment testing is based on a review of forecasted operating cash flows and the profitability of the related brand to determine its fair value. There were no triggering events during the thirteen weeks ended April 29, 2017 that would indicate potential impairment and the requirement to review the carrying value of goodwill and intangible assets. Amortization expense associated with intangible assets subject to amortization is included in depreciation and amortization on the accompanying condensed consolidated statements of operations. Amortization expense for intangible assets subject to amortization was $0.4 million and $0.9 million during the thirteen-weeks ended April 29, 2017 and April 30, 2016, respectively. As of April 29, 2017, estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):
|
Accounting For Share-Based Payments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCOUNTING FOR SHARE-BASED PAYMENTS [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting for Share-Based Payments | ACCOUNTING FOR SHARE-BASED PAYMENTS The 2010 Equity Incentive Plan (the “2010 Plan”) provides for equity-based awards to the Company’s employees, directors and consultants. Under the 2010 Plan, the Company initially reserved 1,000,000 shares of common stock for issuance. This number automatically increases on the first trading day of each fiscal year beginning with fiscal 2011, by an amount equal to 1.5% of the shares of common stock outstanding as of the last trading day of the immediately preceding fiscal year; accordingly, 2,426,711 shares of common stock were reserved for issuance as of April 29, 2017. The Company previously had two stock option plans which expired on October 31, 2010. No further awards will be granted under these plans, although all options previously granted and outstanding will remain outstanding until they are either exercised or forfeited. As of April 29, 2017, 1,059,252 stock options have been granted pursuant to the 2010 Plan. The following is a summary of the stock option activity during the thirteen weeks ended April 29, 2017:
The following is a summary of stock warrants activity during the thirteen weeks ended April 29, 2017:
Share-based compensation expense was less than $0.1 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016. |
Revolving Credit Facility and Notes Payable to Affiliates |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revolving Credit Facility and Notes Payable to Affiliates | REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES The Company’s revolving credit facility and notes payable to affiliates consist of the following:
The Company has a revolving Senior Credit Facility with a syndicate of banks that is used for the Company’s general corporate purposes including working capital and capital expenditures. The maximum borrowing amount under the Senior Credit Facility is $175 million and the termination date is April 2019. Under this facility, which does not require amortization of principal, revolving loans may be drawn, repaid and reborrowed up to the amount available under a borrowing base calculated with reference to specified percentages of the Company’s credit card and trade receivables and inventory, which may be reduced by the lender in its reasonable discretion. The Company must maintain excess availability under the facility of at least $10 million. As of April 29, 2017, the Company had $80.1 million of net availability which includes $25 million for letters of credit. Interest under the Senior Credit Facility is at variable rates plus specified margins that are determined based upon the Company’s excess availability from time to time. The Company is also required to pay monthly commitment fees based on the unused amount of the Senior Credit Facility and a monthly fee with respect to outstanding letters of credit. As of April 29, 2017, the interest rate on outstanding borrowings was 5.0%. All obligations of the Company related to the Senior Credit Facility are secured by first priority perfected security interests in all personal and real property owned by the Company, including without limitation 100% (or, in the case of excluded foreign subsidiaries, 66%) of the outstanding equity interests in the subsidiaries. The Company is subject to customary limitations on its ability to, among other things, pay dividends and make distributions, make investments and enter into joint ventures, and dispose of assets. The Company was in compliance with all financial and operating covenants as of April 29, 2017. In addition, the Company has outstanding unsecured debt obligations to affiliates as follows: (i)a promissory note in the principal amount of $35 million, (the “QKD Note”) held by Quality King Distributors, Inc. ("Quality King"), which provides for payment of principal in quarterly installments between July 31, 2019 and October 31, 2022, with a final installment on October 31, 2022 of the remaining balance, and payment of interest in quarterly installments commencing on January 31, 2011 at the then current senior debt rate, as defined in the Senior Credit Facility, plus 1% per annum; (ii)promissory notes in the aggregate principal amount of approximately $85.4 million held by six estate trusts established by Glenn, Stephen and Arlene Nussdorf (the “Nussdorf Trust Notes”), which provide for payment of the principal in full on July 31, 2019 and payments of interest in quarterly installments commencing on July 31, 2012 at the then current senior debt rate plus 2% per annum; and (iii) a promissory note in the principal amount of $5 million held by Glenn and Stephen Nussdorf (the “2004 Note”), which provided for payment in January 2009 and is currently in default because of the restrictions on payment described below, resulting in an increase of 2% in the nominal interest rate, which is the prime rate plus 1%. These notes are subordinated to the Senior Credit Facility. No principal may be paid on any of them until three months after the Senior Credit Facility terminates and is paid in full, and payment of interest is subject to satisfaction of certain conditions, including the Company’s maintaining excess availability under the Senior Credit Facility of the greater of $17.5 million or 17.5% of the borrowing base certificate after giving effect to the payment, and a fixed charge coverage ratio, as defined in the credit agreement, of 1.1:1.0. Interest expense on these notes was approximately $2.1 million and $1.5 million for the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively, and is included in interest expense on the accompanying condensed consolidated statements of operations. No payments of principal or interest have been made on the QKD Note or the Nussdorf Trust Notes. On the 2004 Note, no payments of principal have been made and no interest payments have been made since October 2008. Accrued interest payable due at April 29, 2017 and January 28, 2017 on the Nussdorf Trust Notes, the QKD Note, and the 2004 Note was approximately $52.9 million and $50.8 million, respectively, and is included in other long-term liabilities on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017, respectively. |
Accounting for Income Taxes |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
ACCOUNTING FOR INCOME TAXES [Abstract] | |
Accounting for Income Taxes | ACCOUNTING FOR INCOME TAXES The Company conducts business throughout the United States, Puerto Rico and the United States Virgin Islands and, as a result, files income tax returns in the U.S. Federal and various state jurisdictions, Puerto Rico and the United States Virgin Islands. In the normal course of business, the Company is subject to examinations in these jurisdictions. With few exceptions, the Company is no longer subject to U.S. Federal, state, local or Puerto Rico income tax examinations for fiscal years prior to 2008. State and foreign income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any Federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states. The Company continues to provide a full valuation allowance against its net deferred tax assets due to the uncertainty as to when and if business conditions will improve sufficiently to enable it to utilize its deferred tax assets. The Company did not record a Federal or state tax expense for the thirteen-week periods ended April 29, 2017 and April 30, 2016, since the Company had a cumulative operating loss for each thirteen-week period. During the thirteen weeks ended April 29, 2017, there were no changes to the liability for income tax associated with uncertain tax positions. The Company accrues interest related to unrecognized tax benefits as well as any related penalties in the income tax provision in its condensed consolidated statements of operations, which is consistent with the recognition of these items in prior reporting periods. The accrual for interest and penalties related to uncertain tax positions as of April 29, 2017 and January 28, 2017 was not significant. The Company does not anticipate any material adjustments relating to unrecognized tax benefits within the next twelve months; however, the ultimate outcome of tax matters is uncertain and unforeseen results can occur. |
Basic and Diluted Net Loss Per Common Share |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
Earnings Per Share [Abstract] | |
Basic and Diluted Net Loss Per Common Share | BASIC AND DILUTED NET LOSS PER COMMON SHARE Basic net loss per common share has been computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share includes, in periods in which they are dilutive, the effect of those potentially dilutive securities where the average market price of the common stock exceeds the exercise prices for the respective periods. During the thirteen-week periods ended April 29, 2017 and April 30, 2016 there were 5,250,639 and 7,135,556, respectively, potential shares of common stock which were excluded from the diluted loss per share calculation because the effect of including these potential shares would have been antidilutive. |
Fair Value Measurements |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
FAIR VALUE MEASUREMENTS [Abstract] | |
Fair Value Measurements | FAIR VALUE MEASUREMENTS The Company applies authoritative accounting guidance regarding fair value and disclosures as it applies to financial and non-financial assets and liabilities. The guidance defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows: Level 1: Observable inputs such as quoted prices in active markets (the fair value hierarchy gives the highest priority to Level 1 inputs); Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data and require the reporting entity to develop its own assumptions. As of April 29, 2017, the Company had no material financial assets or liabilities measured on a recurring basis at fair value. The Company measures certain assets at fair value on a non-recurring basis, specifically long-lived assets evaluated for impairment. No such impairments were recorded during the thirteen-week periods ended April 29, 2017 and April 30, 2016. The fair values of the Company’s assets and liabilities that qualify as financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and short-term debt are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The reported amounts of long-term obligations approximate fair value, given management’s evaluation of the instruments’ current rates compared to market rates of interest and other factors. |
Contingencies |
3 Months Ended |
---|---|
Apr. 29, 2017 | |
CONTINGENCIES [Abstract] | |
Contingencies | CONTINGENCIES On February 21, 2017, Kiss Nail Products, Inc. (Plaintiff) sued Parlux and Roraj Trade, LLC (the licensor of Rihanna’s intellectual property), ("Defendants"), in the U.S. District Court for the Southern District of New York alleging both federal and state law trademark infringement and unfair competition arising out of Parlux’s sale and distribution of the “Kiss by Rihanna” fragrance. Plaintiff alleges that such sale and distribution infringes its “Kiss” mark on nail care and other beauty products. Plaintiff seeks, inter alia, to enjoin Defendants’ distribution and sales of the alleged offending products and seeks unspecified money damages as well as treble damages, attorneys’ fees, punitive damages and interest. Pursuant to an agreement between Parlux and Roraj, Parlux has agreed to defend and indemnify Roraj in this case. On April 19, 2017, the Defendants filed an Answer in the nature of a general denial along with Counterclaims seeking a declaratory judgment that Plaintiff has abandoned the mark with regard to perfume, fragrance, cologne and related fragrance products. Defendants are also seeking a declaration that they have not infringed any of Plaintiff’s marks. The Court has set a schedule which calls for the conclusion of fact and expert discovery on or about December 20, 2017, with dispositive motion practice likely to follow. The Court has also referred the case to a Magistrate Judge for a settlement conference. In August 2015, the Company was named as a defendant in a class action filed in the Superior Court for the State of California, County of Ventura. The plaintiff, a former employee of Perfumania, sought to represent all current and former sales associates at California Perfumania stores. The complaint alleged various violations of California law related to wages, meal periods and wage statements, among other things. In October 2016, the parties agreed in principle on a settlement which has been submitted to the Court. The settlement proceeds will be deposited with the settlement administrator when the court provides its final approval, which is expected sometime in 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016. In November 2015, the Company was named as a defendant in a putative class action in the U.S. District Court for the Southern District of Alabama. The complaint, and thereafter an amended complaint, alleged that the Company violated the Telephone Consumer Protection Act ("TCPA") by sending unsolicited facsimiles which advertised goods and/or services offered by the Company. The plaintiff sought to represent a nationwide class of all recipients of such unsolicited faxes for the period November 3, 2011 to the present. Plaintiff sought statutory damages of at least $500 per violative fax, plus other non-monetary relief. The parties agreed to mediate the matter, which resulted in a settlement in principle. A formal settlement agreement, on a class wide basis, was entered into in late November 2016. Defendants will obtain a release, on a class wide basis, from all members of the settlement class who do not opt out, back to January 2011. The settlement has been preliminarily approved by the Court and notice has been disseminated to potential class members, who had the opportunity to opt out of the class or to object to the settlement on or before March 31, 2017. No objections have been received, but there have been four opt-outs and various claims. The settlement will be presented to the Court for final approval at a hearing currently scheduled for June 29, 2017. Assuming final approval, claims will be submitted, reviewed, and paid as appropriate. It is expected that this process will be concluded during calendar 2017. The Company accrued the estimated settlement of approximately $0.5 million during the thirteen weeks ended October 29, 2016. The Company is involved in various legal proceedings in the ordinary course of business. Management cannot presently predict the outcome of these matters, although management believes, based in part on the advice of counsel, that the ultimate resolution of these matters will not have a materially adverse effect on the Company's consolidated financial position, results of operations or cash flows. See also the discussion of litigation with licensor in Note 11 of this Form 10-Q. |
Related Party Transactions |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions | RELATED-PARTY TRANSACTIONS Glenn, Stephen and Arlene Nussdorf owned an aggregate 7,742,282 shares or approximately 50.0% of the total number of shares of the Company’s outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants and not assuming the exercise of any outstanding options. Stephen Nussdorf has served as the Chairman of the Company’s Board of Directors since February 2004 and Executive Chairman of the Board since April 2011. Glenn Nussdorf is a director of subsidiaries of the Company. The Nussdorfs are officers and principals of Quality King, which distributes pharmaceuticals and health and beauty care products, and the Company’s President and Chief Executive Officer, Michael W. Katz, is also an executive of Quality King. See Note 6 for a discussion of notes payable to affiliates. Transactions With Affiliated Companies Glenn Nussdorf has an ownership interest in Lighthouse Beauty Marketing, LLC, Lighthouse Beauty, LLC and Lighthouse Beauty KLO, LLC (collectively the "Lighthouse Companies"), all of which are manufacturers and distributors of prestige fragrances and have been suppliers to the Company. The Company purchases merchandise from Jacavi Beauty Supply, LLC (“Jacavi”), a fragrance distributor. Jacavi's managing member is Rene Garcia. Rene Garcia, his family trusts and related entities are members of a group (the "Garcia Group") that owned an aggregate 2,211,269 shares, or approximately 14.3%, of the total number of shares of the Company's outstanding common stock as of April 29, 2017, excluding shares issuable upon exercise of certain warrants. See disclosures of merchandise purchases in the table below. The Company sells merchandise to Reba Americas LLC ("Reba"), which distributes fragrances primarily in Puerto Rico and the Caribbean. Family trusts of Rene Garcia own 50% of Reba. Net sales to Reba were approximately $1.1 million and $0.7 million during the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively. The balance due from Reba as of April 29, 2017 and January 28, 2017 was approximately $0.6 million and $0.4 million, respectively, and is included in accounts receivable, net of allowances, on the accompanying condensed consolidated balance sheets. The Company also purchased certain merchandise from Reba during the thirteen-week periods ended April 29, 2017 and April 30, 2016. The amounts due to these related companies are non-interest bearing and are included in accounts payable-affiliates in the accompanying condensed consolidated balance sheets. Transactions for merchandise purchases with these related companies during the thirteen-week periods ended April 29, 2017 and April 30, 2016 were as follows (in thousands):
Glenn, Stephen and Arlene Nussdorf own GSN Trucking, Inc. (“GSN”) which provides general transportation and freight services. The Company periodically utilizes GSN to transport both inbound purchases of merchandise and outbound shipments to wholesale customers. There were no payments to GSN during the thirteen weeks ended April 29, 2017. During the thirteen weeks ended April 30, 2016, total payments to GSN for transportation services provided were less than $0.1 million. There was no balance due to GSN at April 29, 2017 or January 28, 2017. Quality King leases a 560,000 square foot facility in Bellport, NY. The Company began occupying approximately half of this facility in December 2007 under a sublease that terminates on September 30, 2027 and this location serves as the Company’s principal offices. As of April 29, 2017, the monthly current sublease payments are approximately $240,000 and increase by 3% annually. Total payments by the Company to Quality King for this sublease were approximately $0.7 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016, respectively. The Company and Quality King are parties to a Services Agreement providing for the Company’s participation in certain third party arrangements at the Company’s respective share of Quality King’s cost, including allocated overhead, plus a 2% administrative fee, and the provision of legal services. The Company also shares with Quality King the economic benefit of the bulk rate contract that the Company has with UPS to ship Quality King’s merchandise and related items. The Services Agreement will terminate on thirty days’ written notice from either party. The expenses charged under these arrangements to the Company were $0.2 million during each of the thirteen-week periods ended April 29, 2017 and April 30, 2016. The balance due to Quality King for expenses charged under the Services Agreement was $0.1 million and less than $0.1 million at April 29, 2017 and January 28, 2017, respectively. On April 18, 2012, Parlux, Artistic Brands Development LLC (“Artistic Brands”) (a company controlled by Rene Garcia), Shawn C. Carter (who is the beneficial owner of 10% of the Company’s common stock) and S. Carter Enterprises, LLC entered into a sublicense agreement and Artistic Brands, Shawn Carter and S. Carter Enterprises, LLC entered into a license agreement. In connection with these agreements, the Company issued to Artistic Brands and its designees, including Shawn Carter, warrants for the purchase of an aggregate of 1,599,999 shares of the Company's common stock at an exercise price of $8.00 per share. Pursuant to the license agreement, Artistic Brands obtained the exclusive right and license to manufacture, promote, distribute, and sell prestige fragrances and related products under the Jay-Z trademark. The initial term of the license agreement expires at the earlier of (i) five years following the first date on which licensed products are shipped and (ii) December 31, 2018. Artistic Brands has the right to renew the license agreement, so long as certain financial conditions are met and it has not otherwise breached the agreement. Pursuant to the license agreement, Artistic Brands agreed to make certain royalty payments, including certain guaranteed minimum royalties. Pursuant to the sublicense agreement, Artistic Brands sublicensed all rights granted under the license agreement to the Company, and in return the Company assumed all of Artistic Brands' obligations under the license agreement, including making all royalty payments and certain guaranteed minimum royalties owed to S. Carter Enterprises, LLC. No royalties have been paid during the thirteen weeks ended April 29, 2017 or April 30, 2016. On January 25, 2016, the Company and Parlux filed a lawsuit against S. Carter Enterprises, LLC and Shawn C. Carter in the Supreme Court of the State of New York, County of New York. In general, the lawsuit alleges that the defendants have breached the license described above and related agreements by not acting timely or in good faith in approving products and launches under the license and not supporting the brand via personal appearances as required by the license. The lawsuit seeks a determination that such breaches undermine the essence of the license thereby warranting rescission of the license, return of the consideration paid on account of the license and related agreements, monetary damages, and other relief. On May 6, 2016, the defendants filed an answer in the nature of a general denial, with a counterclaim for, inter alia, amounts allegedly due to them under the license agreements in the amount of approximately $2.7 million. The Company has filed a reply to that counterclaim in the nature of a general denial. The Court has set a schedule which calls for the conclusion of fact and expert discovery by January 2018, with dispositive motion practice to follow. On May 5, 2017, the defendants filed a motion for partial summary judgment on their counterclaim. The Company submitted opposition papers on June 9, 2017, and defendants have until June 30 to submit reply papers. Thereafter, the motion will be presented to the Court on July 5, 2017. The Company has announced that a special committee of our independent directors is considering various alternatives to address the Company’s financial condition. The special committee is considering the Company’s capital structure and possible alternatives that could result in value to all shareholders, and has contacted members of the Nussdorf family, our principal shareholders, to begin discussions over possible approaches. The Company does not have a defined timeline for the strategic review process, and there can be no assurance that it will result in any strategic alternative being announced or consummated. |
Segment Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT INFORMATION [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | SEGMENT INFORMATION The Company operates in two industry segments, wholesale distribution and specialty retail sales of designer fragrance and related products. Management reviews segment information by segment and on a consolidated basis each month. Retail sales include sales through Perfumania retail stores, the SOW consignment business and the Company’s internet site, Perfumania.com. Wholesale sales include sales through QFG, Parlux and Five Star to unrelated customers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in the Annual Report on Form 10-K for the fiscal year ended January 28, 2017. The Company’s chief operating decision maker, who is its Chief Executive Officer, assesses segment performance by reference to gross profit. Each of the segments has its own assets, liabilities, revenues and cost of goods sold. While each segment has certain unallocated operating expenses, these expenses are not reviewed by the chief operating decision maker on a segment basis, but rather on a consolidated basis. Financial information for these segments is summarized in the following table:
|
Goodwill and Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Goodwill [Table Text Block] | The following table provides information related to goodwill and intangible assets (in thousands). Intangible assets are included in intangible and other assets, net on the accompanying condensed consolidated balance sheets as of April 29, 2017 and January 28, 2017:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | As of April 29, 2017, estimated future amortization expense associated with intangible assets subject to amortization is as follows (in thousands):
|
Accounting For Share-Based Payments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCOUNTING FOR SHARE-BASED PAYMENTS [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | The following is a summary of the stock option activity during the thirteen weeks ended April 29, 2017:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share-based Compensation, Activity [Table Text Block] | The following is a summary of stock warrants activity during the thirteen weeks ended April 29, 2017:
|
Revolving Credit Facility and Notes Payable to Affiliates (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt [Table Text Block] | The Company’s revolving credit facility and notes payable to affiliates consist of the following:
|
Related Party Transactions (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 29, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Related Party Transactions [Table Text Block] | Transactions for merchandise purchases with these related companies during the thirteen-week periods ended April 29, 2017 and April 30, 2016 were as follows (in thousands):
|
Segment Information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 29, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT INFORMATION [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | Financial information for these segments is summarized in the following table:
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Form 10-Q, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words or phrases such as “may,” “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target,” “forecast,” “objective,” “assume,” “strategies” and other words and terms of similar meaning. Forward-looking statements involve estimates, expectations, projections, goals, forecasts, assumptions, risks and uncertainties. We caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement. Among the factors that could cause actual results, performance or achievement to differ materially from those described or implied in the forward-looking statements are our ability to service our obligations, our ability to comply with the covenants in our Senior Credit Facility, any deterioration of general economic conditions and weaker discretionary spending by consumers, due to various factors including the diminishing patronage by retail customers at malls where our stores are located and other factors included in our filings with the SEC. Copies of our SEC filings are available from the SEC or may be obtained upon request from us. You should also consider carefully the statements under “Risk Factors” in our Form 10-K which address additional factors that could cause our actual results to differ from those set forth in the forward-looking statements and could materially and adversely affect our business, operating results and financial condition. We cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. |
Basis of Presentation and Operations (Details) |
3 Months Ended |
---|---|
Apr. 29, 2017
store
subsidiary
segment
| |
Subsidiaries [Line Items] | |
Number of subsidiaries | subsidiary | 6 |
Number of Operating Segments | segment | 2 |
Subsidaries, Perfumania [Member] | |
Subsidiaries [Line Items] | |
Number of Stores | 240 |
Subsidiaries, Scents of Worth [Member] | |
Subsidiaries [Line Items] | |
Number of Stores | 1,100 |
Subsidiaries, Scents of Worth [Member] | Kmart [Member] | |
Subsidiaries [Line Items] | |
Number of Stores | 600 |
Maximum [Member] | Subsidaries, Perfumania [Member] | |
Subsidiaries [Line Items] | |
Product Pricing, Discount from Manufacturer's Suggested Retail Price | 75.00% |
Allowance for Doubtful Accounts (Details) $ in Millions |
Apr. 30, 2016
USD ($)
|
---|---|
Receivables [Abstract] | |
Allowance for Doubtful Accounts Receivable | $ 1.7 |
Goodwill and Intangible Assets - Schedule of Future Amortization (Details) $ in Thousands |
Apr. 29, 2017
USD ($)
|
---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | |
Remainder of Current Fiscal Year | $ 1,065 |
2015 | 877 |
2016 | 709 |
2017 | 684 |
2018 | 682 |
2019 | 235 |
Total | $ 4,252 |
Goodwill and Intangible Assets - Textuals (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Apr. 29, 2017 |
Apr. 30, 2016 |
Jan. 28, 2017 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Goodwill | $ 38,769 | $ 38,769 | |
Amortization of Intangible Assets | $ 400 | $ 900 |
Accounting For Share-Based Payments - Textuals (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Apr. 29, 2017 |
Oct. 29, 2016 |
Apr. 30, 2016 |
Oct. 31, 2015 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 1,000,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Annual Percentage Increase in Shares Authorized | 1.50% | |||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 2,426,711 | |||
Share-based compensation expense | $ 34 | $ 13 | $ 32 | $ 43 |
The 2010 Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Outstanding at end of period (number of shares) | 1,059,252 |
Revolving Credit Facility and Notes Payable to Affiliates - Schedule (Details) - USD ($) $ in Thousands |
Apr. 29, 2017 |
Jan. 28, 2017 |
Oct. 29, 2016 |
Jan. 30, 2016 |
---|---|---|---|---|
REVOLVING CREDIT FACILITY AND NOTES PAYABLE TO AFFILIATES [Abstract] | ||||
Revolving credit facility | $ 4,517 | $ 0 | $ 4,517 | $ 0 |
Subordinated notes payable, affiliates | $ 125,366 | $ 125,366 | 125,366 | 125,366 |
Debt, current and noncurrent | 129,883 | 125,366 | ||
Less current portion | 0 | 0 | ||
Total long-term debt | $ 129,883 | $ 125,366 |
Basic and Diluted Net Loss Per Common Share - Textuals (Details) - shares |
3 Months Ended | |||
---|---|---|---|---|
Apr. 29, 2017 |
Jul. 30, 2016 |
Apr. 30, 2016 |
Aug. 01, 2015 |
|
Earnings Per Share [Abstract] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 5,250,639 | 7,132,723 | 7,135,556 | 7,405,635 |
Segment Information (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Apr. 29, 2017 |
Apr. 30, 2016 |
Jan. 28, 2017 |
|||
Segment Reporting Information [Line Items] | |||||
Revenue from External Customers | $ 97,896 | $ 105,139 | |||
Gross Profit | 44,969 | 51,769 | |||
Assets | 304,739 | $ 312,800 | |||
Retail Segment [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Revenue from External Customers | 46,794 | 51,675 | |||
Gross Profit | 22,136 | 26,329 | |||
Assets | 368,466 | 364,117 | |||
Wholesale Segment [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Revenue from External Customers | 51,102 | 53,464 | |||
Gross Profit | 22,833 | $ 25,440 | |||
Assets | 699,812 | 681,055 | |||
Operating Segments [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Assets | 1,068,278 | 1,045,172 | |||
Intersegment Elimination [Member] | |||||
Segment Reporting Information [Line Items] | |||||
Assets | [1] | $ (763,539) | $ (732,372) | ||
|
C"93,5;3I>_F.'DWYZU\#\N);_ 5!+ P04
M " "/B--*DF&SP"D# "O# & 'AL+W=O %WN;3'O
M4YFNE[6X.'6W'JI4+SMR$ZCIVNK.=G;:WU0]&]5[7@-+EMY9$_6838>!$88,
M"$^Q#Q* 26S "H=K@3L;$037D'L;$H;7D =$!Q@^4(K6@K8$](H@P D82L!:
M C8BB(Q4-QTD:B%E"Z',J(8-(=2H!L)B"#W8$$;Q7 (TE\#*!0(?)PA1@G!^
M-2.4($)&0(QR=IA@E&4(29)$$PLT1H5B1,B WM@5CRCL ">X[]']=:DQGX
M+$6?^O9ZTI%##]J93VKP-R"8 =5:0I/X)DM^+\,3)@?O>E,$96Q'OO'CKO9)$9'(@9>]_Q\,3;0^)[4P9G;$6\\^*M
M]UZ*;7J3L4L@FF*.8TRRC)DCF&>?4R1K*8[)!WBR#M^M*MQ%^.X?A?MU@G25
M((T$Z7]+7(OY_"X)6_14@6GB-%E28J_C)"^\\\#>)O%-_H:/T_[(32.T)6=T
M_F5C_VM$!U[*YLJ/4.L_V&Q(J%TXWOBS&<=L-!QVTP]B\SGJ<)NTA:UF3/'7&I*LS_982R=N/Z[FWC
MI3P74F^ -&GPF?PD\E>SYVH%!I5C69%:E*QV.#EMW"?_<>=[FF 0OTO2BM'<
MT:D<&'O5BV_'C>OIB @EN=026 U7LB64:B45Q]]>U!T\-7$\OZE_,1T=+IMM.ZNM=';8E:LL7C;S<;M[#CWVVW,GZMM
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M\=D)?1J\9O&EYV"'F&E'?4^= %_TB=?94 9VDJ1%".IQ/@7A5Z(6DN#/K .D^#?,<*)[6+(#!DET(8X?WRICUGDE($G9*
M)"1D.BMCZ\B<<1P"2=>#%V8>%<$>(G>-Q%#K"N> 4D0 2OP *HY7.
M._E-Z_G*026- UQ$#!^2)$J3W\MD2C,QAVMS0_KL)^3R17TFA,UQ*1W9S8BI
MG<-
#C;$JOW?3
MG[L@@F!='>W1V7^N#GK]0_565E%;'OK?,[-=]5_.]=ZI%P/A(R_580_,GF;_
MM84:H#TGO>_WCH
19U$%(PH7VLRS=I[CL;@8
M?$?5)C JN'P-VQ^]K.^^.:N^L5W;"*&&VSC:=]S]>N
[7+#E!T'&!E;3O&C1< 1UU1A*
MK;=68T5*-V-VT90OXT$/9PK